Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Autolymphocyte Therapy (ALT) For Patients With Non-Metastatic Renal Cell Carcinoma
NCT00002589Phase 2Unknown
- Sponsor
- National Cancer Institute
- Start
- Jul 1994
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of therapeutic autologous lymphocytes in renal cell carcinoma (RCC), sponsored by National Cancer Institute. Status: unknown.
02
Drugs
therapeutic autologous lymphocytes
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00002589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002589.